Elanco Animal Health Inc. has announced the appointment of Robert VanHimbergen as the new Chief Financial Officer, effective July 7, 2025. VanHimbergen will succeed Todd Young, who will stay on as an advisor until August 31, 2025, to ensure a smooth transition. This leadership change follows a comprehensive search aimed at supporting Elanco's strategy for sustained growth and innovation. The company also reaffirmed its second quarter and full year financial guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.